ARVN
ARVN
NASDAQ · Pharmaceuticals

Arvinas Inc

$8.14
+0.40 (+5.17%)
Analyst Consensus
Buy
26
Analysts
High
Coverage
Buy 16 62%
Hold 9 35%
Sell 1 4%
Price Target
Analyst Price Target +713.5% upside
Low Target $44.47
Average Target $66.22
High Target $75.30
Current Price $8.14
Current
$8.14
Target
$66.22
$44.47 $66.22 avg $75.30
Scenario Analysis
Bear Case
$44.47
446.3%
Low target
Base Case
$66.22
+713.5%
Avg target
Bull Case
$75.30
+825.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$14.51
-43.9% from high
52-Week Low
$6.06
+34.3% from low
Target vs 52W High
$66.22
+356.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%